NASDAQ:STAA - STAAR Surgical Stock Price, Price Target & More

Get Started

$26.60 +0.25 (+0.95 %)

(As of 05/21/2018 04:00 PM ET)

Previous Close$26.35

Today's Range$26.15 - $27.10

52-Week Range$8.95 - $27.10

Volume426,900 shs

Average Volume215,321 shs

Market Capitalization$1.10 billion

P/E Ratio2,660.00

Dividend YieldN/A

Beta1.21

About STAAR Surgical (NASDAQ:STAA)

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers minimally invasive intraocular lenses (IOLs), including foldable IOLs for use in minimally invasive cataract surgical procedures; aspheric IOLs that produce a clearer image than traditional spherical lenses; and nanoFLEX IOL, a single piece collamer aspheric optic, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision centers, surgical centers, hospitals, government facilities, and distributors primarily under the STAAR, EVO Visian ICL, Evolution in Visual Freedom, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX, nanoPOINT, and Afinity trademarks. The company sells products directly through its sales representatives in the United States, Japan, Spain, Germany, Canada, the United Kingdom, and Singapore, as well as through independent distributors in approximately 75 countries. STAAR Surgical Company was founded in 1982 and is headquartered in Monrovia, California.

Receive STAA News and Ratings via Email

Sign-up to receive the latest news and ratings for STAA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Ophthalmic goods

Sub-IndustryHealth Care Supplies

SectorMedical

SymbolNASDAQ:STAA

CUSIP85231230

Webwww.staar.com

Phone626-303-7902

Debt

Debt-to-Equity Ratio0.03

Current Ratio2.43

Quick Ratio1.90

Price-To-Earnings

Trailing P/E Ratio2,660.00

Forward P/E Ratio886.67

P/E GrowthN/A

Sales & Book Value

Annual Sales$90.61 million

Price / Sales12.22

Cash Flow$0.0923 per share

Price / Cash288.25

Book Value$1.04 per share

Price / Book25.58

Profitability

EPS (Most Recent Fiscal Year)$0.01

Net Income$-2,130,000.00

Net Margins0.66%

Return on Equity6.80%

Return on Assets4.04%

Miscellaneous

Employees353

Outstanding Shares41,620,000

STAAR Surgical (NASDAQ:STAA) Frequently Asked Questions

What is STAAR Surgical's stock symbol?

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

How were STAAR Surgical's earnings last quarter?

STAAR Surgical (NASDAQ:STAA) released its earnings results on Wednesday, May, 2nd. The medical instruments supplier reported $0.04 earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.08. The medical instruments supplier had revenue of $27.09 million for the quarter, compared to the consensus estimate of $23 million. STAAR Surgical had a return on equity of 6.80% and a net margin of 0.66%. During the same quarter last year, the business posted ($0.05) earnings per share. View STAAR Surgical's Earnings History.

When is STAAR Surgical's next earnings date?

STAAR Surgical is scheduled to release their next quarterly earnings announcement on Wednesday, August, 1st 2018. View Earnings Estimates for STAAR Surgical.

What price target have analysts set for STAA?

4 analysts have issued 1-year target prices for STAAR Surgical's shares. Their predictions range from $21.00 to $23.00. On average, they expect STAAR Surgical's stock price to reach $21.6667 in the next twelve months. View Analyst Ratings for STAAR Surgical.

What are Wall Street analysts saying about STAAR Surgical stock?

Here are some recent quotes from research analysts about STAAR Surgical stock:

1. Canaccord Genuity analysts commented, "We hosted CEO Caren Mason for a day of investor meetings in the Mid- Atlantic last week, coming away from discussions with increased conviction in the merits of the STAA turnaround story. We think management has “primed the pump” (product pipeline) extraordinary well, and expect STAA to deliver revenue growth acceleration through 2020 at least. Timing of FDA re-inspection and Warning Letter “lift” is in the agency’s court, but we continue to get the sense that the firm has dedicated significant resources to satisfy FDA inspectors once they commence their unannounced visit. The US market clearly represents an enormous potential growth engine for STAA, so removal of the Warning Letter could be a bullish catalyst for the stock, in our view." (4/24/2018)
2. According to Zacks Investment Research, "Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma. " (4/12/2018)

Who are some of STAAR Surgical's key competitors?

Some companies that are related to STAAR Surgical include Elekta (EKTAY), GW Pharmaceuticals (GWPH), Premier (PINC), FibroGen (FGEN), Orion (ORINY), Ligand Pharmaceuticals (LGND), Syneos Health (SYNH), Ablynx (ABLX), LivaNova (LIVN), DiaSorin (DIA), Ablynx (ABLYF), Inogen (INGN), Neogen (NEOG), ConvaTec Group (CTEC) and Acadia Healthcare (ACHC).

Who are STAAR Surgical's key executives?

STAAR Surgical's management team includes the folowing people:

Ms. Caren L. Mason, Chief Exec. Officer, Pres and Director (Age 64)
Dr. Keith Holliday, Chief Technology Officer (Age 55)
Mr. Samuel J. Gesten J.D., Chief Legal Officer & Corp. Sec. (Age 56)
Mr. Hans-Martin Blickensdoerfer, Sr. VP of Commercial Operations - Europe & China (Age 53)
Ms. Deborah Andrews, Chief Financial Officer (Age 61)

Has STAAR Surgical been receiving favorable news coverage?

Media headlines about STAA stock have been trending somewhat positive this week, Accern reports. The research firm identifies negative and positive press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. STAAR Surgical earned a news impact score of 0.17 on Accern's scale. They also gave press coverage about the medical instruments supplier an impact score of 48.04 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

Who are STAAR Surgical's major shareholders?

STAAR Surgical's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Palo Alto Investors LP (8.45%), BlackRock Inc. (6.53%), Baillie Gifford & Co. (2.58%), Cortina Asset Management LLC (0.95%), Millennium Management LLC (0.79%) and Principal Financial Group Inc. (0.50%). Company insiders that own STAAR Surgical stock include Broadwood Partners Lp, Caren L Mason, Deborah J Andrews, Hans-Martin Blickensdoerfer, Keith Holliday and Samuel J Gesten. View Institutional Ownership Trends for STAAR Surgical.

Which major investors are selling STAAR Surgical stock?

STAA stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Cortina Asset Management LLC, Lincoln National Corp, A.R.T. Advisors LLC, Principal Financial Group Inc., Principal Financial Group Inc., Barclays PLC and Public Employees Retirement Association of Colorado. Company insiders that have sold STAAR Surgical company stock in the last year include Caren L Mason, Deborah J Andrews, Keith Holliday and Samuel J Gesten. View Insider Buying and Selling for STAAR Surgical.

Which major investors are buying STAAR Surgical stock?

STAA stock was bought by a variety of institutional investors in the last quarter, including Baillie Gifford & Co., King Luther Capital Management Corp, Next Century Growth Investors LLC, BlackRock Inc., Millrace Asset Group Inc., Palo Alto Investors LP, Element Capital Management LLC and GSA Capital Partners LLP. View Insider Buying and Selling for STAAR Surgical.

How do I buy shares of STAAR Surgical?

Shares of STAA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is STAAR Surgical's stock price today?

One share of STAA stock can currently be purchased for approximately $26.60.

How big of a company is STAAR Surgical?

STAAR Surgical has a market capitalization of $1.10 billion and generates $90.61 million in revenue each year. The medical instruments supplier earns $-2,130,000.00 in net income (profit) each year or $0.01 on an earnings per share basis. STAAR Surgical employs 353 workers across the globe.

How can I contact STAAR Surgical?

STAAR Surgical's mailing address is 1911 WALKER AVENUE, MONROVIA CA, 91016. The medical instruments supplier can be reached via phone at 626-303-7902 or via email at d[email protected]

MarketBeat Community Rating for STAAR Surgical (STAA)

Community Ranking:		1.9 out of 5 ()
Outperform Votes:		129 (Vote Outperform)
Underperform Votes:		218 (Vote Underperform)
Total Votes:		347

MarketBeat's community ratings are surveys of what our community members think about STAAR Surgical and other stocks. Vote "Outperform" if you believe STAA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe STAA will underperform the S&P 500 over the long term. You may vote once every thirty days.

STAAR Surgical (NASDAQ:STAA) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

4 Wall Street analysts have issued ratings and price targets for STAAR Surgical in the last 12 months. Their average twelve-month price target is $21.6667, suggesting that the stock has a possible downside of 18.55%. The high price target for STAA is $23.00 and the low price target for STAA is $21.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	3.00	3.00	3.00	3.00
Ratings Breakdown:	0 Sell Rating(s) 0 Hold Rating(s) 4 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$21.6667	$20.50	$20.50	$20.50
Price Target Upside:	18.55% downside	25.77% upside	25.77% upside	25.77% upside

STAAR Surgical (NASDAQ:STAA) Consensus Price Target History

Price Target History for STAAR Surgical (NASDAQ:STAA)

STAAR Surgical (NASDAQ:STAA) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
5/3/2018	Canaccord Genuity	Boost Price Target	Buy ➝ Buy	$21.00 ➝ $23.00	High
5/3/2018	Stephens	Upgrade	Equal Weight ➝ Overweight	$13.00 ➝ $21.00	High
4/30/2018	William Blair	Upgrade	Market Perform ➝ Outperform		Medium
11/20/2017	Benchmark	Reiterated Rating	Buy ➝ Buy	$21.00	N/A

(Data available from 5/21/2016 forward)

STAAR Surgical (NASDAQ:STAA) Earnings History and Estimates Chart

Earnings by Quarter for STAAR Surgical (NASDAQ:STAA)

STAAR Surgical (NASDAQ:STAA) Earnings Estimates

Current Year EPS Consensus Estimate: $0.03 EPS
Next Year EPS Consensus Estimate: $0.17 EPS

STAAR Surgical (NASDAQ STAA) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
7/31/2018		($0.02)					N/A
5/2/2018	Q1 2018	($0.04)	$0.04	$23.00 million	$27.09 million	View	Listen
2/28/2018	Q4 2017	$0.03	$0.02		$24.85 million	View	Listen
11/8/2017	Q3 2017	$0.02	$0.02		$23.47 million	View	N/A
8/2/2017	Q2 2017	($0.0470)	($0.01)	$22.15 million	$21.90 million	View	Listen
5/3/2017	Q1 2017	($0.0530)	($0.05)		$20.35 million	View	Listen
3/2/2017	Q4 2016	($0.02)	$0.02	$22.25 million	$22.10 million	View	Listen
11/3/2016	Q316	($0.04)	($0.02)	$20.70 million	$20.05 million	View	Listen
8/3/2016	Q216	($0.05)	($0.05)	$19.88 million	$21.00 million	View	Listen
5/11/2016	Q116	($0.17)	($0.01)	$19.60 million	$19.30 million	View	Listen
3/2/2016	Q415	($0.02)	$0.01	$19.11 million	$20.90 million	View	Listen
10/28/2015	Q315	($0.04)	($0.04)	$17.87 million	$18.80 million	View	Listen
7/29/2015	Q2 2015		($0.02)	$18.20 million	$18.66 million	View	N/A
4/29/2015	Q115	($0.04)	$0.03	$17.85 million	$18.90 million	View	Listen
2/25/2015	Q414	($0.05)	($0.03)	$16.60 million	$16.60 million	View	Listen
10/30/2014	Q314	$0.02	($0.04)	$19.53 million	$18.20 million	View	Listen
7/30/2014	Q214	$0.03	$0.01	$19.80 million	$20.05 million	View	Listen
4/28/2014	Q114	$0.01	$0.04	$19.44 million	$20.20 million	View	Listen
2/26/2014	Q413	$0.02	$0.02	$18.98 million	$18.90 million	View	Listen
10/30/2013	Q313	$0.02	$0.04	$17.35 million	$17.10 million	View	Listen
7/31/2013	Q2 2013	$0.04	$0.05	$17.40 million	$18.20 million	View	Listen
5/1/2013	Q1 2013	$0.04	$0.08	$17.27 million	$18.00 million	View	Listen
2/27/2013	Q4 2012	$0.03	$0.01	$17.55 million	$16.50 million	View	Listen
10/31/2012	Q312	$0.01	$0.04	$16.78 million	$15.90 million	View	N/A
8/1/2012		$0.03	$0.03			View	N/A
5/2/2012		$0.03	$0.04			View	N/A
3/6/2012	Q4 2011	$0.02	$0.02			View	N/A
10/24/2011	Q3 2011	$0.02	$0.01			View	N/A
8/2/2011	Q2 2011	$0.01	$0.02			View	N/A
5/3/2011	Q1 2011		$0.01			View	N/A
3/1/2011	Q4 2010	$0.01	($0.02)			View	N/A
11/2/2010	Q3 2010	$0.01	($0.03)			View	N/A
8/3/2010	Q2 2010		($0.02)			View	N/A
5/4/2010	Q1 2010	($0.01)	($0.02)			View	N/A
3/2/2010	Q4 2009	($0.03)	($0.06)			View	N/A
11/2/2009	Q3 2009	($0.03)	($0.05)			View	N/A
8/3/2009	Q2 2009	($0.01)	($0.04)			View	N/A
5/5/2009	Q1 2009	($0.05)	$0.02			View	N/A
3/16/2009	Q4 2008	($0.04)	($0.12)			View	N/A
10/28/2008	Q3 2008	($0.07)	($0.08)			View	N/A
7/30/2008	Q2 2008	($0.10)	($0.09)			View	N/A
5/6/2008	Q1 2008	($0.12)	($0.30)			View	N/A
3/6/2008	Q4 2007	($0.10)	($0.15)			View	N/A

(Earnings results data provided by Zacks Investment Research)

STAAR Surgical (NASDAQ:STAA) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

STAAR Surgical (NASDAQ STAA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.90%
Institutional Ownership Percentage: 78.92%

Insider Trading History for STAAR Surgical (NASDAQ:STAA)

Institutional Ownership by Quarter for STAAR Surgical (NASDAQ:STAA)

STAAR Surgical (NASDAQ STAA) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/3/2018	Deborah J Andrews	CFO	Sell	13,331	$17.60	$234,625.60	28,998
3/22/2018	Deborah J Andrews	CFO	Sell	333	$16.05	$5,344.65	15,667
3/22/2018	Keith Holliday	CTO	Sell	2,188	$16.03	$35,073.64	43,781
3/22/2018	Samuel J Gesten	Insider	Sell	2,833	$16.05	$45,469.65	38,316
3/20/2018	Keith Holliday	Insider	Sell	1,458	$16.05	$23,400.90	45,969
3/19/2018	Caren L Mason	CEO	Sell	6,667	$16.09	$107,272.03	51,513
11/21/2017	Keith Holliday	VP	Sell	6,000	$16.65	$99,900.00	45,969
12/9/2016	Hans-Martin Blickensdoerfer	VP	Sell	25,000	$11.14	$278,500.00	137,380
6/29/2016	Broadwood Partners Lp	Major Shareholder	Buy	14,144	$5.24	$74,114.56
5/25/2016	Broadwood Partners Lp	Major Shareholder	Buy	77,842	$5.16	$401,664.72
5/24/2016	Broadwood Partners Lp	Major Shareholder	Buy	70,000	$5.16	$361,200.00
5/23/2016	Broadwood Partners Lp	Major Shareholder	Buy	3,138	$5.24	$16,443.12
5/20/2016	Richard A Meier	Director	Sell	25,000	$5.35	$133,750.00	27,149
5/17/2016	Broadwood Partners Lp	Major Shareholder	Buy	9,313	$5.23	$48,706.99
5/16/2016	Broadwood Partners Lp	Major Shareholder	Buy	336,210	$5.49	$1,845,792.90
2/9/2016	Broadwood Partners Lp	Major Shareholder	Buy	91,770	$6.25	$573,562.50
2/3/2016	Broadwood Partners Lp	Major Shareholder	Buy	121,599	$6.40	$778,233.60
2/1/2016	Broadwood Partners Lp	Major Shareholder	Buy	65,983	$6.48	$427,569.84
1/27/2016	Broadwood Partners Lp	Major Shareholder	Buy	239,013	$6.63	$1,584,656.19
1/26/2016	Broadwood Partners Lp	Major Shareholder	Buy	112,900	$6.60	$745,140.00
1/25/2016	Broadwood Partners Lp	Major Shareholder	Buy	81,752	$6.74	$551,008.48
1/20/2016	Broadwood Partners Lp	Major Shareholder	Buy	72,858	$6.75	$491,791.50
1/15/2016	Broadwood Partners Lp	Major Shareholder	Buy	135,725	$6.73	$913,429.25
1/11/2016	Broadwood Partners Lp	Major Shareholder	Buy	86,586	$6.83	$591,382.38
1/7/2016	Broadwood Partners Lp	Major Shareholder	Buy	267,047	$6.95	$1,855,976.65
1/4/2016	Broadwood Partners Lp	Major Shareholder	Buy	165,461	$7.11	$1,176,427.71
9/29/2015	Broadwood Partners Lp	Major Shareholder	Buy	311,099	$7.08	$2,202,580.92
8/25/2015	Broadwood Partners Lp	Major Shareholder	Buy	188,881	$7.17	$1,354,276.77
8/24/2015	Caren L Mason	CEO	Buy	10,000	$7.34	$73,400.00	14,500
4/6/2015	Samuel J Gesten	VP	Sell	3,223	$7.14	$23,012.22
3/3/2015	Robin Hughes	VP	Sell	23,253	$15.82	$367,862.46
11/19/2014	Broadwood Partners Lp	Major Shareholder	Buy	189,646	$8.64	$1,638,541.44
11/18/2014	Broadwood Partners Lp	Major Shareholder	Buy	39,400	$8.67	$341,598.00
11/17/2014	Broadwood Partners Lp	Major Shareholder	Buy	118,200	$8.63	$1,020,066.00
11/10/2014	Broadwood Partners Lp	Major Shareholder	Buy	500	$8.79	$4,395.00
11/7/2014	Broadwood Partners Lp	Major Shareholder	Buy	80,000	$8.92	$713,600.00
11/4/2014	Broadwood Partners Lp	Major Shareholder	Buy	260,341	$9.20	$2,395,137.20
5/15/2014	John Moore	Director	Sell	2,800	$14.87	$41,636.00	76,000
3/19/2014	James Francese	VP	Sell	16,666	$17.22	$286,988.52	21,960
3/17/2014	Robin Hughes	VP	Sell	5,672	$16.61	$94,211.92	56,818
9/4/2013	Deborah Andrews	CFO	Sell	50,000	$12.88	$644,000.00	36,400
8/20/2013	Deborah Andrews	CFO	Sell	33,515	$11.65	$390,449.75	36,400
8/12/2013	Deborah Andrews	CFO	Sell	9,079	$11.62	$105,497.98	22,621
8/7/2013	Deborah Andrews	CFO	Sell	11,721	$11.79	$138,190.59	24,639
5/9/2013	Deborah J Andrews	CFO	Sell	5,000	$8.96	$44,800.00
12/11/2012	John C Moore	Director	Buy	5,000	$5.46	$27,300.00
11/15/2012	Broadwood Partners Lp	Major Shareholder	Buy	2,618	$5.00	$13,090.00
11/15/2012	Mark B Logan	Director	Buy	3,600	$5.22	$18,792.00
11/14/2012	Barry G Caldwell	CEO	Buy	5,000	$5.04	$25,200.00
11/2/2012	Broadwood Partners Lp	Major Shareholder	Buy	22,572	$5.00	$112,860.00
8/9/2012	Barry G Caldwell	CEO	Buy	5,000	$6.57	$32,850.00

(Data available from 1/1/2013 forward)

STAAR Surgical (NASDAQ STAA) News Headlines

Source:

Date	Headline
	STAAR Surgical (STAA) Upgraded at BidaskClub www.americanbankingnews.com - May 18 at 1:19 PM
	STAAR Surgical (STAA) Upgraded by TheStreet to "B-" www.americanbankingnews.com - May 16 at 1:49 PM
	STAAR Surgical (STAA) Upgraded by ValuEngine to "Buy" www.americanbankingnews.com - May 12 at 10:38 AM
	STAAR Surgical (STAA) CFO Sells $234,625.60 in Stock www.americanbankingnews.com - May 7 at 4:34 PM
	STAAR Surgical (STAA) vs. The Cooper Companies (COO) Head-To-Head Contrast www.americanbankingnews.com - May 4 at 3:29 PM
	STAAR Surgical (STAA) Given New $23.00 Price Target at Canaccord Genuity www.americanbankingnews.com - May 4 at 12:17 AM
	STAAR Surgical (STAA) Lifted to Overweight at Stephens www.americanbankingnews.com - May 3 at 4:31 PM
	STAAR Surgical shoots 21% post Q1 results seekingalpha.com - May 3 at 3:37 PM
	Mid-Day Market Update: Dow Down Over 250 Points; STAAR Surgical Shares Spike Higher feeds.benzinga.com - May 3 at 1:38 PM
	Why Shares of STAAR Surgical Company Are Soaring Today www.fool.com - May 3 at 1:21 PM
	BRIEF-STAAR Surgical Reports Q1 EPS Of $0.01 www.reuters.com - May 3 at 10:23 AM
	STAAR Surgical Co. (STAA) Has Broken Out To A New High On Q1 Results www.nasdaq.com - May 3 at 10:23 AM
	STAAR Surgical's (STAA) CEO Caren Mason on Q1 2018 Results - Earnings Call Transcript seekingalpha.com - May 3 at 10:23 AM
	Staar Surgical: 1Q Earnings Snapshot finance.yahoo.com - May 3 at 10:23 AM
	STAAR Surgical Reports First Quarter 2018 Results; Revenue Increases 33 Percent on Accelerating EVO Visian ™ ICL Momentum finance.yahoo.com - May 3 at 10:23 AM
	Edited Transcript of STAA earnings conference call or presentation 2-May-18 8:30pm GMT finance.yahoo.com - May 3 at 10:23 AM
	STAAR Surgical (STAA) Posts Earnings Results, Beats Expectations By $0.02 EPS www.americanbankingnews.com - May 2 at 10:02 PM
	Financial Analysis: STAAR Surgical (STAA) & The Cooper Companies (COO) www.americanbankingnews.com - May 2 at 3:20 AM
	STAAR Surgical (STAA) Given Consensus Recommendation of "Hold" by Brokerages www.americanbankingnews.com - April 30 at 11:37 AM
	STAAR Surgical (STAA) Upgraded to Outperform at William Blair www.americanbankingnews.com - April 30 at 9:54 AM
	STAAR Surgical (STAA) to Release Quarterly Earnings on Wednesday www.americanbankingnews.com - April 25 at 5:47 AM
	STAAR Surgical (STAA) Rating Reiterated by Canaccord Genuity www.americanbankingnews.com - April 24 at 9:06 PM
	Matthew Haverland Slated To Helm Staar Surgical Company www.prnewswire.com - April 20 at 10:57 AM
	STAAR Surgical to Report First Quarter Results on May 2, 2018 finance.yahoo.com - April 18 at 10:39 AM
	Zacks: STAAR Surgical (STAA) Receives Consensus Rating of "Buy" from Analysts www.americanbankingnews.com - April 17 at 11:08 PM
	STAAR Surgical (STAA) Cut to Sell at BidaskClub www.americanbankingnews.com - April 17 at 9:57 AM
	STAAR Surgical (STAA) and The Cooper Companies (COO) Head to Head Analysis www.americanbankingnews.com - April 15 at 1:21 AM
	The Cooper Companies (COO) & STAAR Surgical (STAA) Head to Head Survey www.americanbankingnews.com - April 15 at 1:21 AM
	STAAR Surgical (STAA) Downgraded to "Sell" at Zacks Investment Research www.americanbankingnews.com - April 12 at 11:18 AM
	STAAR Surgical (STAA) Rating Lowered to Sell at Zacks Investment Research www.americanbankingnews.com - April 6 at 10:45 AM
	Contrasting National Vision (EYE) and STAAR Surgical (STAA) www.americanbankingnews.com - April 4 at 9:34 PM
	Zacks: STAAR Surgical (STAA) Receives Consensus Recommendation of "Buy" from Brokerages www.americanbankingnews.com - April 2 at 7:28 AM
	STAAR Surgical (STAA) Downgraded to "Hold" at BidaskClub www.americanbankingnews.com - March 29 at 9:15 AM
	STAAR Surgical (STAA) Rating Increased to Buy at BidaskClub www.americanbankingnews.com - March 23 at 7:56 PM
	Keith Holliday Sells 2,188 Shares of STAAR Surgical (STAA) Stock www.americanbankingnews.com - March 22 at 2:40 PM
	Insider Selling: STAAR Surgical (STAA) Insider Sells 2,833 Shares of Stock www.americanbankingnews.com - March 22 at 2:40 PM
	Insider Selling: STAAR Surgical (STAA) Insider Sells 1,458 Shares of Stock www.americanbankingnews.com - March 21 at 7:50 PM
	Insider Selling: STAAR Surgical (STAA) CEO Sells 6,667 Shares of Stock www.americanbankingnews.com - March 21 at 7:34 PM
	Edited Transcript of STAA earnings conference call or presentation 28-Feb-18 9:30pm GMT finance.yahoo.com - March 18 at 10:52 AM
	BidaskClub Upgrades STAAR Surgical (STAA) to Hold www.americanbankingnews.com - March 10 at 11:00 PM
	STAAR Surgical (STAA) Position Trimmed by Millrace Asset Group Inc. www.americanbankingnews.com - March 5 at 12:54 PM
	BRIEF-Staar Surgical Q4 Sales $24.9 Million www.reuters.com - March 2 at 3:35 PM
	STAAR Surgical beats by $0.03, beats on revenue seekingalpha.com - March 2 at 3:35 PM
	Form 8-K STAAR SURGICAL CO For: Feb 28 www.streetinsider.com - March 2 at 3:35 PM
	STAAR Surgical Reports Fourth Quarter and Full Year 2017 Results finance.yahoo.com - March 1 at 10:34 AM
	STAAR Surgical (STAA) Issues Quarterly Earnings Results www.americanbankingnews.com - February 28 at 7:04 PM
	Cortina Asset Management LLC Trims Holdings in STAAR Surgical (STAA) www.americanbankingnews.com - February 28 at 1:27 PM
	Was STAAR Surgical Company’s (NASDAQ:STAA) Earnings Growth Better Than The Industry’s? finance.yahoo.com - February 28 at 10:25 AM
	74,178 Shares in STAAR Surgical (STAA) Acquired by Barrow Hanley Mewhinney & Strauss LLC www.americanbankingnews.com - February 24 at 11:52 AM
	STAAR Surgical (STAA) Scheduled to Post Quarterly Earnings on Wednesday www.americanbankingnews.com - February 21 at 2:40 AM

STAAR Surgical (NASDAQ:STAA) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

STAAR Surgical (NASDAQ:STAA) Income Statement, Balance Sheet and Cash Flow Statement

STAAR Surgical (NASDAQ STAA) Stock Chart for Monday, May, 21, 2018

Loading chart…

This page was last updated on 5/21/2018 by MarketBeat.com Staff